Global Biodefense Market Analysis, Growth, Trends & Forecast 2018-2023, With an Expected CAGR of 6.5% - ResearchAndMarkets.com

August 7, 2018

DUBLIN--(BUSINESS WIRE)--Aug 7, 2018--The “Global Biodefense Market - Segmented by Product and Geography - Growth, Trends, and Forecast (2018 - 2023)” report has been added to ResearchAndMarkets.com’s offering.

The global biodefense market is expected to register a CAGR of 6.5% during the forecast period, 2018 to 2023.

Bioterrorism is the use of biological agents that are harmful for mankind. Biodefense includes medical measures to protect from biological agents. Key factors driving the market growth are rise in technological advancement, such as nanotechnology, database management systems, advanced detector hardware, and gene chips for pathogen detection in the forensic department. Also, the rise in the production of vaccines, enhanced forensics, and quick diagnostic procedures and detection techniques are the factors expected to drive the market growth.

Governments spend huge sums of money every year for the R&D of vaccines in order stay prepared for any bioterrorism attacks. Pharmaceutical companies operating in the biodefense sector have huge opportunities to expand due to governments’ drive to be prepare for any kind of bioterrorism.

North America dominated the global biodefense market in 2017, which can be attributed to the increase in government funding to generate and stockpile sufficient vaccines to be used against anthrax through various initiative, such as BioShield act, Biomedical Advanced Research and Development Authority (BARDA), and Joint Program Executive Office for Chemical & Biological Defense. For instance, the US Department of Health and Human Services announced it plans to spend more than USD 25 million on an anthrax antitoxin, as a part of an emergency preparedness plan in 2018.

Companies Mentioned

Alnylam Pharmaceuticals Inc. Bavarian Nordic Cleveland BioLabs DynPort Vaccine Company LLC Elusys Therapeutics Inc. Emergent BioSolutions Inc. Ichor Medical Systems Ology Bioscience PharmAthene Inc. SIGA Technologies Industries Ltd

Key Topics Covered:

1. Introduction

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Market Overview

6. Drivers, Restraints, Opportunities and Challenges Analysis (DROC)

7. Market Segmentation

8. Competitive Landscape

9. Key Players

10. Future of the Market

For more information about this report visit https://www.researchandmarkets.com/research/4p79tj/global_biodefense?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180807005360/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Biodefense



SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 08/07/2018 05:51 AM/DISC: 08/07/2018 05:51 AM


Update hourly